Agilent Technologies Americas — Net revenue decreased by 12.6% to $678.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.3%, from $669.00M to $678.00M. Over 4 years (FY 2021 to FY 2025), Americas — Net revenue shows an upward trend with a 3.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests successful market expansion or stronger demand in the Americas, while a decrease may indicate regional economic headwinds or loss of market share to competitors.
This metric represents the total gross sales generated from products and services within the Americas geographic region....
Comparable to regional revenue reporting by other global life sciences and diagnostics companies, often benchmarked against regional GDP growth and industry-specific capital expenditure trends.
a_segment_americas_net_revenue| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $581.00M | $606.00M | $662.00M | $637.00M | $659.00M | $671.00M | $715.00M | $687.00M | $676.00M | $667.00M | $702.00M | $630.00M | $637.00M | $626.00M | $680.00M | $669.00M | $678.00M | $683.00M | $776.00M | $678.00M |
| QoQ Change | — | +4.3% | +9.2% | -3.8% | +3.5% | +1.8% | +6.6% | -3.9% | -1.6% | -1.3% | +5.2% | -10.3% | +1.1% | -1.7% | +8.6% | -1.6% | +1.3% | +0.7% | +13.6% | -12.6% |
| YoY Change | — | — | — | — | +13.4% | +10.7% | +8.0% | +7.8% | +2.6% | -0.6% | -1.8% | -8.3% | -5.8% | -6.1% | -3.1% | +6.2% | +6.4% | +9.1% | +14.1% | +1.3% |